Nyxoah

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nyxoah and other ETFs, options, and stocks.

About NYXH

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. 

CEO
Olivier Taelman
CEOOlivier Taelman
Employees
184
Employees184
Headquarters
Mont-Saint-Guibert, Walloon Region
HeadquartersMont-Saint-Guibert, Walloon Region
Founded
2009
Founded2009
Employees
184
Employees184

NYXH Key Statistics

Market cap
292.98M
Market cap292.98M
Price-Earnings ratio
-3.64
Price-Earnings ratio-3.64
Dividend yield
Dividend yield
Average volume
44.29K
Average volume44.29K
High today
$7.86
High today$7.86
Low today
$7.71
Low today$7.71
Open price
$7.76
Open price$7.76
Volume
17.90K
Volume17.90K
52 Week high
$11.87
52 Week high$11.87
52 Week low
$5.55
52 Week low$5.55

Analyst ratings

78%

of 9 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

People also own

Based on the portfolios of people who own NYXH. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.